Ogiso Y - Search Results

1

Suppressive effects of dominant negative ras mutant N116Y on transformed phenotypes of human bladder cancer cells.

Watanabe T, Shinohara N, Sazawa A, Kobayashi Y, Ogiso Y, Kimura T, Takiguchi M, Yasuda J, Hashimoto A, Koyanagi T, Kuzumaki N. Watanabe T, et al. Among authors: ogiso y. Cancer Lett. 2000 Feb 28;149(1-2):195-202. doi: 10.1016/s0304-3835(99)00359-6. Cancer Lett. 2000. PMID: 10737724

2

Suppression of various human tumor cell lines by a dominant negative H-ras mutant.

Ogiso Y, Sakai N, Watari H, Yokoyama T, Kuzumaki N. Ogiso Y, et al. Gene Ther. 1994 Nov;1(6):403-7. Gene Ther. 1994. PMID: 7584106

3

Gelsolin: a candidate for suppressor of human bladder cancer.

Tanaka M, Müllauer L, Ogiso Y, Fujita H, Moriya S, Furuuchi K, Harabayashi T, Shinohara N, Koyanagi T, Kuzumaki N. Tanaka M, et al. Among authors: ogiso y. Cancer Res. 1995 Aug 1;55(15):3228-32. Cancer Res. 1995. PMID: 7614452

4

Resistance of NIH3T3 cells to v-fes transformation induced by a dominant negative H-ras mutant.

Ogiso Y, Yokoyama T, Watari H, Shih TY, Kuzumaki N. Ogiso Y, et al. Exp Cell Res. 1993 Oct;208(2):415-21. doi: 10.1006/excr.1993.1263. Exp Cell Res. 1993. PMID: 7690710

5

Differential Na+,K(+)-ATPase activity and cisplatin sensitivity between transformants induced by H-ras and those induced by K-ras.

Shinohara N, Ogiso Y, Arai T, Takami S, Nonomura K, Koyanagi T, Kuzumaki N. Shinohara N, et al. Among authors: ogiso y. Int J Cancer. 1994 Sep 1;58(5):672-7. doi: 10.1002/ijc.2910580510. Int J Cancer. 1994. PMID: 8077052

6

Biological activity of a K-ras mutant that contains the 12R/59T/116Y mutations.

Ogiso Y, Hwang YW, Shih TY, Kuzumaki N. Ogiso Y, et al. Cancer Lett. 1993 Nov 30;75(1):19-26. doi: 10.1016/0304-3835(93)90202-k. Cancer Lett. 1993. PMID: 8287379

7

The significance of Ras guanine nucleotide exchange factor, son of sevenless protein, in renal cell carcinoma cell lines.

Shinohara N, Ogiso Y, Tanaka M, Sazawa A, Harabayashi T, Koyanagi T. Shinohara N, et al. Among authors: ogiso y. J Urol. 1997 Sep;158(3 Pt 1):908-11. doi: 10.1097/00005392-199709000-00070. J Urol. 1997. PMID: 9258117

8

Suppression of Erk activation and in vivo growth in esophageal cancer cells by the dominant negative Ras mutant, N116Y.

Senmaru N, Shichinohe T, Takeuchi M, Miyamoto M, Sazawa A, Ogiso Y, Takahashi T, Okushiba S, Takimoto M, Kato H, Kuzumaki N. Senmaru N, et al. Among authors: ogiso y. Int J Cancer. 1998 Oct 29;78(3):366-71. doi: 10.1002/(SICI)1097-0215(19981029)78:3<366::AID-IJC18>3.0.CO;2-4. Int J Cancer. 1998. PMID: 9766573 Free article.

9

Significance of the Grb2 and son of sevenless (Sos) proteins in human bladder cancer cell lines.

Watanabe T, Shinohara N, Moriya K, Sazawa A, Kobayashi Y, Ogiso Y, Takiguchi M, Yasuda J, Koyanagi T, Kuzumaki N, Hashimoto A. Watanabe T, et al. Among authors: ogiso y. IUBMB Life. 2000 Apr;49(4):317-20. doi: 10.1080/15216540050033195. IUBMB Life. 2000. PMID: 10995035 Free article.

10

An improved intravesical model using human bladder cancer cell lines to optimize gene and other therapies.

Watanabe T, Shinohara N, Sazawa A, Harabayashi T, Ogiso Y, Koyanagi T, Takiguchi M, Hashimoto A, Kuzumaki N, Yamashita M, Tanaka M, Grossman HB, Benedict WF. Watanabe T, et al. Among authors: ogiso y. Cancer Gene Ther. 2000 Dec;7(12):1575-80. doi: 10.1038/sj.cgt.7700261. Cancer Gene Ther. 2000. PMID: 11228536

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

139 results

Search Page

Filters